chr20-23036202-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001052.4(SSTR4):c.719C>T(p.Ala240Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000539 in 1,613,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001052.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SSTR4 | NM_001052.4 | c.719C>T | p.Ala240Val | missense_variant | 1/1 | ENST00000255008.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SSTR4 | ENST00000255008.5 | c.719C>T | p.Ala240Val | missense_variant | 1/1 | NM_001052.4 | P1 | ||
ENST00000440921.6 | n.827-2021C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000564 AC: 14AN: 248186Hom.: 0 AF XY: 0.0000445 AC XY: 6AN XY: 134766
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460840Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 726768
GnomAD4 genome AF: 0.000289 AC: 44AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | The c.719C>T (p.A240V) alteration is located in exon 1 (coding exon 1) of the SSTR4 gene. This alteration results from a C to T substitution at nucleotide position 719, causing the alanine (A) at amino acid position 240 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at